Hepatocellular carcinoma biology predicts survival outcome after liver transplantation in the USA
PURPOSE: The aim of this study is to evaluate the clinicopathologic prognostic factors of cancer-specific survival (CSS) in hepatocellular carcinoma (HCC) patients who underwent liver transplantation (LT) stratified by tumor size.
METHODS: From the Surveillance, Epidemiology, and End Results (SEER) 18 registries (2004-2012), we retrieved data of 570 patients who underwent LT for a solitary primary HCC lesion ≤5 cm. A two multivariable Cox models were constructed to identify prognostic factors of CSS in a two different tumor sizes (2 cm cutoff).
RESULTS: Out of 570 HCC patients (median age 57 years), 16% had microvascular invasion (MVI) and 12% had a poorly differentiated tumor. Male sex (odds ratio [OR] 2.6), tumor size >2 cm (OR 1.78), elevated AFP (OR 2.31), and poor tumor differentiation (OR 2.59) are significant predictors of MVI. With a median follow up of 41.5 months (range 1-107 months), the 5-year CSS rate was 90% in the absence of MVI compared to 75% in the presence of MVI (p<0.001). Multivariate models revealed that age ≥60 years (hazard ratio [HR] 2.08), MVI (HR 2.26), and poor tumor differentiation (HR 2.42), were significant risk factors of a dismal CSS with HCC size >2 cm, but not with HCC ≤2 cm.
CONCLUSIONS: Primary HCC tumor size ≤2 cm had an excellent prognosis after LT and was not affect by the presence of MVI or poor tumor differentiation.
Errataetall: |
CommentIn: Indian J Gastroenterol. 2017 Mar;36(2):77-80. - PMID 28357774 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
---|---|
Enthalten in: |
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology - 36(2017), 2 vom: 28. März, Seite 117-125 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
El-Fattah, Mohamed Abd [VerfasserIn] |
---|
Links: |
---|
Themen: |
HCC |
---|
Anmerkungen: |
Date Completed 21.09.2017 Date Revised 26.11.2019 published: Print-Electronic CommentIn: Indian J Gastroenterol. 2017 Mar;36(2):77-80. - PMID 28357774 Citation Status MEDLINE |
---|
doi: |
10.1007/s12664-017-0732-x |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM268930848 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM268930848 | ||
003 | DE-627 | ||
005 | 20231224223554.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s12664-017-0732-x |2 doi | |
028 | 5 | 2 | |a pubmed24n0896.xml |
035 | |a (DE-627)NLM268930848 | ||
035 | |a (NLM)28194604 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a El-Fattah, Mohamed Abd |e verfasserin |4 aut | |
245 | 1 | 0 | |a Hepatocellular carcinoma biology predicts survival outcome after liver transplantation in the USA |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 21.09.2017 | ||
500 | |a Date Revised 26.11.2019 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: Indian J Gastroenterol. 2017 Mar;36(2):77-80. - PMID 28357774 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a PURPOSE: The aim of this study is to evaluate the clinicopathologic prognostic factors of cancer-specific survival (CSS) in hepatocellular carcinoma (HCC) patients who underwent liver transplantation (LT) stratified by tumor size | ||
520 | |a METHODS: From the Surveillance, Epidemiology, and End Results (SEER) 18 registries (2004-2012), we retrieved data of 570 patients who underwent LT for a solitary primary HCC lesion ≤5 cm. A two multivariable Cox models were constructed to identify prognostic factors of CSS in a two different tumor sizes (2 cm cutoff) | ||
520 | |a RESULTS: Out of 570 HCC patients (median age 57 years), 16% had microvascular invasion (MVI) and 12% had a poorly differentiated tumor. Male sex (odds ratio [OR] 2.6), tumor size >2 cm (OR 1.78), elevated AFP (OR 2.31), and poor tumor differentiation (OR 2.59) are significant predictors of MVI. With a median follow up of 41.5 months (range 1-107 months), the 5-year CSS rate was 90% in the absence of MVI compared to 75% in the presence of MVI (p<0.001). Multivariate models revealed that age ≥60 years (hazard ratio [HR] 2.08), MVI (HR 2.26), and poor tumor differentiation (HR 2.42), were significant risk factors of a dismal CSS with HCC size >2 cm, but not with HCC ≤2 cm | ||
520 | |a CONCLUSIONS: Primary HCC tumor size ≤2 cm had an excellent prognosis after LT and was not affect by the presence of MVI or poor tumor differentiation | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a HCC | |
650 | 4 | |a Hepatocellular carcinoma | |
650 | 4 | |a Liver transplantation | |
650 | 4 | |a Microvascular invasion | |
650 | 4 | |a Prognosis | |
773 | 0 | 8 | |i Enthalten in |t Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology |d 1993 |g 36(2017), 2 vom: 28. März, Seite 117-125 |w (DE-627)NLM012713031 |x 0975-0711 |7 nnns |
773 | 1 | 8 | |g volume:36 |g year:2017 |g number:2 |g day:28 |g month:03 |g pages:117-125 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s12664-017-0732-x |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 36 |j 2017 |e 2 |b 28 |c 03 |h 117-125 |